
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Netherlands), Netherlands, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
562
Total Open
Publications
275
Total
Citations
16K
Open Access
Percentage
49%
Total
Publications
562
Total Open
Publications
275
Total
Citations
16K
Breakdown
Publisher Open
18%
Both
29%
Other Platform Open
2%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
71
Hybrid 51%
134
No Guarantees 22%
57
Other Platform Open
Domain 71%
122
Institution 31%
54
Other Internet 20%
35
Public 2%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 121 |
DOI | Other Internet | 31 |
DANS - Data Archiving and Networked Services | Institution | 23 |
Europe PMC | Domain | 15 |
Digital Access to Libraries | Institution | 8 |
University of Bristol - Bristol Research | Institution | 7 |
Imperial College London - Spiral | Institution | 6 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 5 |
Unknown Repository | Other Internet | 4 |
University of Melbourne - Minerva Access | Institution | 3 |